Mettler-Toledo International, Inc. $MTD Shares Bought by Fundsmith LLP

Fundsmith LLP lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 0.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 590,654 shares of the medical instruments supplier’s stock after acquiring an additional 617 shares during the quarter. Mettler-Toledo International accounts for about 3.7% of Fundsmith LLP’s holdings, making the stock its 11th biggest position. Fundsmith LLP owned about 2.89% of Mettler-Toledo International worth $725,093,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Geneos Wealth Management Inc. raised its holdings in Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 30 shares during the last quarter. Savant Capital LLC grew its holdings in Mettler-Toledo International by 27.0% in the second quarter. Savant Capital LLC now owns 471 shares of the medical instruments supplier’s stock valued at $553,000 after purchasing an additional 100 shares during the last quarter. Penserra Capital Management LLC increased its position in shares of Mettler-Toledo International by 10.7% in the second quarter. Penserra Capital Management LLC now owns 114 shares of the medical instruments supplier’s stock valued at $133,000 after buying an additional 11 shares in the last quarter. Los Angeles Capital Management LLC increased its position in shares of Mettler-Toledo International by 82.7% in the second quarter. Los Angeles Capital Management LLC now owns 550 shares of the medical instruments supplier’s stock valued at $646,000 after buying an additional 249 shares in the last quarter. Finally, Acadian Asset Management LLC raised its stake in shares of Mettler-Toledo International by 12.3% during the 2nd quarter. Acadian Asset Management LLC now owns 2,823 shares of the medical instruments supplier’s stock worth $3,312,000 after buying an additional 310 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Up 0.6%

MTD opened at $1,174.59 on Friday. The firm has a market cap of $23.88 billion, a P/E ratio of 27.89, a PEG ratio of 2.45 and a beta of 1.43. The business’s fifty day simple moving average is $1,378.52 and its 200 day simple moving average is $1,367.96. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share for the quarter, beating the consensus estimate of $12.76 by $0.60. The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on MTD. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Wall Street Zen upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a report on Monday, December 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Finally, Morgan Stanley dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 10th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $1,435.42.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.